The CNPs, as compared to that of free ormeloxifene against the MCF-7 and MDA-MB-231 breast cancer cell lines, were able to display an increased cellular uptake, apoptosis, stimulation of caspase-3, destruction of the membrane of the mitochondria, cytotoxicity in a dose-dependent way. The gene discussed is CASP3; the disease is breast carcinoma.